The introduction of PET scans that can image more than one radiotracer simultaneously could revolutionize oncology by ...
Among over 76,000 women who received external beam radiation therapy (EBRT) for breast cancer between 2002 and 2017, those with left-sided disease had only slightly higher rates of heart failure and ...
Prostate cancer is the most commonly diagnosed cancer in men worldwide, accounting for more than 1.4 million new cases each year. For many patients, radiotherapy is a standard treatment option that ...
Increasing radiation doses to the whole heart appear to correlate with higher risks of valvular disease, coronary artery disease, and heart failure in childhood cancer survivors, a recent study found.
Breast cancer radiotherapy has evolved significantly over recent decades, with advances in imaging, treatment planning and delivery techniques contributing to both improved tumour control and reduced ...
A shorter course of prostate cancer radiotherapy, involving fewer hospital visits and higher individual doses of radiotherapy, is as effective as the current standard treatment for both survival and ...
Radiotherapy induces DNA damage and oxidative stress, leading to endothelial injury and blood-brain barrier disruption, which triggers neuroinflammation, microvascular dysfunction, and neuronal ...
Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new Phase III randomized trial.
Adjuvant radiotherapy reduces the risk for short-term recurrence in patients with early breast cancer, but it may have no impact on long-term recurrence or overall survival, based on a 30-year ...
Dr. Mohammad Hissourou III explains how radiation therapy has evolved to be more accurate and gentle. Sponsored by Overlake ...
An oncological radiotherapy centre was inaugurated at the Bucharest University Emergency Hospital on Tuesday, being equipped with state-of-the-art equipment and modern treatment techniques. On Tuesday ...